SLC2A4, solute carrier family 2 member 4, 6517

N. diseases: 158; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.800 AlteredExpression disease BEFREE Western blot results revealed that the expression of Akt, PI3K, IRS-1, and GLUT4 were upregulated in skeletal muscle of type 2 diabetes (T2D) rats and in L6 myotubes by Ph. 28223777 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE Importantly, the dysfunction of insulin-regulated GLUT4 trafficking is strongly linked with peripheral insulin resistance and type 2 diabetes in human. 28529958 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.800 AlteredExpression disease BEFREE GLUT4 content and its activation as well as SLC2A4 gene expression level are decreased in patients with type 2 diabetes. 26529385 2016
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE Increased STX8 expression in VAT appears to be associated with the presence of T2D in obese patients through a mechanism that may involve GLUT4. 25523146 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE Our findings manifest that EK100 may have therapeutic potential in treating type 2 diabetes associated with hyperlipidemia in HFD-fed mice by regulation of GLUT4, PEPCK, G6 Pase, SREBP1c, SREBP2, apo A-I, and AMPK phosphorylation. 25693659 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE GLUT4 function is impaired in obesity and type 2 diabetes leading to hyperglycemia and an increased risk of cardiovascular disease and neuropathy. 25596527 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.800 AlteredExpression disease BEFREE H(2) significantly increased skeletal muscle membrane Glut4 expression and markedly improved glycemic control in STZ-induced type 1 diabetic mice after chronic intraperitoneal (i.p.) and oral (p.o.) administration.However, long-term p.o. administration of H(2) had least effect on the obese and non-insulin-dependent type 2 diabetes mouse models. 23326534 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.800 AlteredExpression disease BEFREE Our findings showed that adipose GLUT4 gene expression changes were more related to insulin resistance and type 2 diabetes rather than to obesity. 21604201 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.800 GeneticVariation disease BEFREE Recent studies in south Indian populations revealed that haplotypes of the GLUT4 gene associated with type 2 diabetes. 22673408 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE The aim of this study was the estimation of insulin resistance indicators and the quantitative expression of GLUT-1, GLUT-3 and GLUT-4 on peripheral blood lymphocytes in prediabetic subjects and persons with a positive family history of type 2 diabetes during 24 months of observation. 22744628 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease CTD_human All our results have thus highlighted the potential of Rut as both a valuable lead compound for anti-T2DM drug discovery and a promising chemical probe for GLUT4 associated pathways exploration. 22384078 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE All our results have thus highlighted the potential of Rut as both a valuable lead compound for anti-T2DM drug discovery and a promising chemical probe for GLUT4 associated pathways exploration. 22384078 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE Insulin-stimulated glucose uptake by the glucose transporter GLUT4 plays a central role in whole-body glucose homeostasis, dysregulation of which leads to type 2 diabetes. 22473005 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.800 GeneticVariation disease BEFREE The changes in AMPK-α protein content significantly related (p < 0.001) to the changes in GLUT-4 translocation (r = 0.78) and Hb1Ac levels (r = -0.68), suggesting that AMPK signaling may be implicated in the effects of supplementation on glucose uptake in type 2 diabetes. 22349765 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.800 AlteredExpression disease BEFREE In conclusion, a single bout of exercise increased skeletal muscle GLUT4 mRNA expression in patients with T2D to a similar extent as in control subjects. 22340256 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE Moreover, GLUT4, a member of the solute carrier family 2, may play a role in the patient's type 2 diabetes. 22365944 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE The GLUT4 gene was sequenced in 25 normal glucose tolerance (NGT) and 25 T2DM subjects, and the variants found were then genotyped by polymerase chain reaction-restriction fragment length polymorphism in a pilot study population of 552 NGT and 643 T2DM subjects, randomly selected from the Chennai Urban Rural Epidemiology Study. 21668369 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.800 AlteredExpression disease BEFREE GLUT4 protein levels may therefore play a role in the pathology behind type 2 diabetes mellitus among subgroups of patients, and this may explain the heterogeneous response to insulin treatment. 22114711 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.800 GeneticVariation disease BEFREE Haplotype analysis revealed that two common haplotypes H1 (111, P = 0.001, OR 1.23[1.08-1.40]) and H2 (222, P = 0.002 OR 0.73[0.59-0.89]) in STRA6, H6 (2121, P = 0.006, OR 1.69[1.51-2.48]) in RBP4 and H4 (2121, P = 0.01 OR 1.41[1.07-1.85]) in GLUT4 were associated with type 2 diabetes. 20625434 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.800 GeneticVariation disease BEFREE The goal of the present study is to develop a cell-based assay for identifying negative regulators of GLUT4 translocation as potential targets for the treatment of Type 2 diabetes. 19035854 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.800 AlteredExpression disease BEFREE Adaptation to states of enhanced metabolic demand is associated with increased glucose metabolism and GLUT4 gene expression, whereas states of insulin resistance such as type 2 diabetes mellitus (DM2), obesity, and aging are associated with impaired regulation of GLUT4 gene expression and function. 18492767 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.800 AlteredExpression disease BEFREE Type 2 diabetes mellitus and obesity are associated with impaired regulation of GLUT4 gene expression and elevated levels of free fatty acids and proinflammatory factors. 17317207 2007
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE Gene expressions of insulin receptor (INSR), vitamin D receptor, insulin degrading enzyme, Akt, insulin receptor substrate-1 (IRS-1), IRS-2, glucose transporter 4 (GLUT4), and enzymes of the glycolytic pathway were decreased at least 50% in T2DM than in controls. 18267303 2007
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease CTD_human Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S. Air force veterans of the Vietnam war. 17107852 2006
Diabetes Mellitus, Non-Insulin-Dependent
0.800 Biomarker disease BEFREE In conclusion, the uncoupling of insulin action on Akt/AS160 signaling and glucose transport implicates defective GLUT4 trafficking as an early event in the pathogenesis of type 2 diabetes. 16644684 2006